COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 72 of 990 for:    tablet | Japan

ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT) (ACROBAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01748253
Recruitment Status : Unknown
Verified May 2013 by Acrobat Trial Group.
Recruitment status was:  Recruiting
First Posted : December 12, 2012
Last Update Posted : May 21, 2013
Information provided by (Responsible Party):
Acrobat Trial Group

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : October 2013
Study Completion Date : No date given